4//SEC Filing
Collins Cooper C. 4
Accession 0001387131-19-003731
CIK 0000025743other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 5:03 PM ET
Size
5.3 KB
Accession
0001387131-19-003731
Insider Transaction Report
Form 4
Collins Cooper C.
Director
Transactions
- Purchase
Common Stock
2019-05-13$3.33/sh+30,000$99,870→ 66,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.32 to $3.33, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001485508
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 5:03 PM ET
- Size
- 5.3 KB